Dermatology · Myrtle Beach, SC
NPI
1154373827
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3001 Newcastle Loop, Attn: Lisa Bass
Myrtle Beach, SC, 29588
Phone (843) 215-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$450K
10,504 services
Medicare patients, 2024
1,152
Average age 76
Drug cost, 2024
$1.4M
1,953 prescriptions
Company payments, 2025
$3,760
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert S Purvis was code 17003 (destruction skin lesion), 3,722 times for 523 patients. In total Robert S Purvis billed 10,504 services in 94 codes, and Medicare paid $450K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,722 | 523 | $4.54 | $17K |
| 99213 Office E&M - Established | Office | 1,174 | 784 | $62.60 | $73K |
| 17110 Destruction Skin Lesion | Office | 1,018 | 728 | $72.09 | $73K |
| 17000 Destruction Skin Lesion | Office | 926 | 627 | $29.76 | $28K |
| 88305 Surgical Pathology Examination | Office | 499 | 321 | $26.66 | $13K |
| 11102 Skin Biopsy | Office | 397 | 331 | $49.24 | $20K |
| 99214 Office E&M - Established | Office | 277 | 243 | $89.24 | $25K |
| 17004 Destruction Skin Lesion | Office | 275 | 180 | $108.12 | $30K |
| 99212 Office E&M - Established | Office | 256 | 198 | $39.07 | $10K |
| 11900 Skin | Office | 159 | 100 | $29.21 | $4,644 |
| 99203 Office E&M - New | Office | 149 | 149 | $72.76 | $11K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 148 | 90 | $0.78 | $115 |
| 17111 Destruction Skin Lesion | Office | 106 | 97 | $81.11 | $8,597 |
| 11103 Skin Biopsy | Office | 101 | 63 | $36.36 | $3,673 |
| 87220 General Laboratory | Office | 79 | 75 | $4.18 | $330 |
By year: 2022 $594K for 13,708 services; 2023 $318K for 8,234 services; 2024 $450K for 10,504 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 499 | 321 | $26.66 | $13K |
| 87220 General Laboratory | 79 | 75 | $4.18 | $330 |
| Q0112 All potassium hydroxide (koh) preparations | 23 | 20 | $5.71 | $131 |
| 88304 Surgical Pathology Examination | 14 | 14 | $10.08 | $141 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert S Purvis prescribed most often to Medicare patients was Ketoconazole, with 367 prescriptions and refills. In total Robert S Purvis wrote 1,953 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 367 | 386 | 213 | $5,182 |
| Mupirocin Generic | 224 | 225 | 183 | $1,662 |
| Gentamicin Sulfate Generic | 154 | 156 | 131 | $5,131 |
| Finasteride Generic | 130 | 205 | 44 | $1,056 |
| Doxycycline Hyclate Generic | 109 | 141 | 49 | $2,186 |
| Fluocinonide Generic | 87 | 100 | 53 | $3,064 |
| Mometasone Furoate Generic | 85 | 96 | 70 | $1,315 |
| Terbinafine Hcl Generic | 52 | 120 | 40 | $1,030 |
| Dupixent Pen Dupilumab | 43 | 49 | Under 11 | $186K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 41 | 41 | 34 | $174 |
| Triamcinolone Acetonide Generic | 40 | 47 | 27 | $615 |
| Clindamycin Phosphate Generic | 38 | 42 | 18 | $1,117 |
| Fluconazole Generic | 37 | 63 | 20 | $688 |
| Jublia Efinaconazole | 35 | 46 | 21 | $33K |
| Ciclopirox Generic | 33 | 33 | 21 | $1,051 |
Brand drugs: 296 claims; generic drugs: 1,657 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert S Purvis $3,760 ($3,760 in general payments such as food, travel and fees) from 22 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $602.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 17 | $602 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $394 |
| Genzyme Corporation SNY | 7 | $343 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $321 |
| Abbvie Inc. ABBV | 13 | $309 |
| Incyte Corporation INCY | 7 | $299 |
| LEO Pharma Inc. | 5 | $292 |
| Arcutis Biotherapeutics, Inc. ARQT | 5 | $224 |
| Janssen Biotech, Inc. JNJ | 6 | $157 |
| Galderma Laboratories, L.P. GALD.SW | 11 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.